Relmada Therapeutics Inc. (RLMD) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Relmada Therapeutics Inc.

    NASDAQ: RLMD · Real-Time Price · USD
    2.06
    -0.26 (-11.21%)
    At close: Oct 06, 2025, 12:23 PM

    Relmada Therapeutics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -79.98M -98.79M -157.04M -125.75M
    Depreciation & Amortization
    		 n/a n/a n/a 1.26K
    Stock-Based Compensation
    		 30.19M 43.81M 44.19M 40.49M
    Other Working Capital
    		 -2.21M 4.32M 10.6M -10.71M
    Other Non-Cash Items
    		 -381.66K 241.31K -1.55M 1.25M
    Deferred Income Tax
    		 n/a n/a n/a n/a
    Change in Working Capital
    		 -1.58M 3.08M 10.59M -7.86M
    Operating Cash Flow
    		 -51.76M -51.66M -103.8M -91.87M
    Capital Expenditures
    		 n/a -4 -3 -5
    Cash Acquisitions
    		 n/a n/a n/a n/a
    Purchase of Investments
    		 -12.08M -90.46M -47.29M -222.98M
    Sales Maturities Of Investments
    		 63.64M 140.92M 67.03M 168.86M
    Other Investing Acitivies
    		 n/a n/a n/a n/a
    Investing Cash Flow
    		 51.56M 50.45M 19.73M -54.12M
    Debt Repayment
    		 n/a n/a n/a n/a
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 -287.09K -98.46K 2.29M 2.63M
    Financial Cash Flow
    		 -40.34K -98.46K 45.02M 187.94M
    Net Cash Flow
    		 -234.54K -1.3M -39.05M 41.95M
    Free Cash Flow
    		 -51.76M -51.66M -103.8M -91.87M

    Add to Watchlist